ALX Oncology Doses First Patient in Phase 1 Trial of ALX1004
ALX Oncology has initiated a Phase 1 trial of ALX2004, an epidermal growth factor receptor (EGFR) antibody-drug conjugate (ADC),...
eClinical Tech News
Capricor Doses First Subjects in Phase 1 Exosome Vaccine Trial
Capricor Therapeutics has initiated a Phase 1 trial of its StealthX™ exosome-based vaccine platform. The trial, funded by the...
Ascentage Pharma’s Lisaftoclax Enters Phase III Trial for Myelodysplastic Syndrome
Ascentage Pharma has secured both FDA and EMA clearance for its global Phase 3 GLORA-4 trial evaluating lisaftoclax, a...
Jabez BioSciences Opens Second Site in Oncology Study
Jabez Biosciences has opened a second clinical site for its Phase 1 trial of JBZ-001, a dihydroorotate dehydrogenase (DHODH)...
BioAge Labs Doses First Patient in BGE-102 Phase 1 Trial
BioAge Labs has initiated a Phase 1 trial of BGE-102, an oral NLRP3 inhibitor, in healthy volunteers. Initial single...
Global Clinical Trial Supplies Market to Reach $8.18B by 2030
The global clinical trial supplies market, valued at $5.34 billion in 2025, is projected to reach $8.18 billion by...
Invivyd and FDA Align on Accelerated Approval for COVID-19 Antibody
Invivyd has received FDA guidance on a streamlined Phase 2/3 trial design for VYD2311, its monoclonal antibody (mAb) candidate...
Lixte Biotech Oncology Pipeline Advances: Phase 1b/2 Trial Results Due 2H 2025
LIXTE Biotechnology Holdings (Nasdaq: LIXT) anticipates preliminary efficacy data in Q4 2025 from its Phase 1b/2 trial of LB-100,...
Tiziana Doses First Patient in Trial of Intranasal Foralumab for MSA
Tiziana Life SciencesLife Sciences has dosed the first participant in a Phase 2a trial of intranasal foralumab for multiple...
Orchestra Biomed’s AVIM Therapy Shows Promise in Hypertension
Echocardiographic analysis from the MODERATO II study suggests that atrioventricular interval modulation (AVIM) therapy has a positive impact on...